The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
Established in June 2017, VALIDATE is an international network of researchers working to accelerate vaccine development for four neglected intracellular pathogens that cause significant mortality and morbidity globally: Mycobacterium tuberculosis, Leishmania spp., Burkholderia pseudomallei and Mycob...
Main Authors: | Vermaak, S, Sampson, S, McShane, H |
---|---|
Format: | Book section |
Language: | English |
Published: |
Springer
2023
|
Similar Items
-
VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy
by: Fletcher, H, et al.
Published: (2018) -
VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy [version 1; referees: 2 approved]
by: Helen A. Fletcher, et al.
Published: (2018-04-01) -
Insights and challenges in tuberculosis vaccine development
by: McShane, H
Published: (2019) -
Vaccines for tuberculosis
by: McShane, H
Published: (2013) -
Vaccine strategies against tuberculosis
by: H McShane
Published: (2009-03-01)